publication date: Dec. 12, 2014

Senate Debates $1.1 Trillion “Cromnibus” Bill That Includes a $150 Million Increase for NIH


Early Friday morning, President Barack Obama signed a two-day funding resolution averting a government shutdown and giving the Senate time to debate a $1.1 trillion funding package passed by the House of Representatives late Thursday night.

The year-long “cromnibus” bill—a Washington-speak portmanteau of continuing resolution and omnibus—passed by a 219-to-206 vote three hours before government funding expired.

NIH is slated to receive a half-percent increase in the 1,603-page spending bill.

“The NIH total in the Labor-HHS portion of the bill is $30.084 billion and NCI is $4.95 billion,” NIH officials said to The Cancer Letter. “That’s an increase of $150 million and $27 million, respectively, over the FY 2014 enacted levels.”

NCI’s increase comes to 0.54 percent.

The legislation would also double the funds—from $25 million to $50 million—for melanoma and other cancer research at the Department of Defense’s Peer Reviewed Cancer Research Program.

The House, having completed its last day of legislating for the year, leaves the Senate little choice but to approve the funding bill before midnight on Saturday to keep the government funded through September 2015.

Obama and other White House officials lobbied for the bill, leading dozens of House Democrats to break with Minority Leader Nancy Pelosi (D-Calif.) and back the legislation.

The administration said the bill is worth supporting because it would provide $5.4 billion to fight Ebola and $5 billion for military operations to combat the Islamic State in Iraq and Syria. The measure also provides uninterrupted funding for … Continue reading 40-46 Senate Debates $1.1 Trillion “Cromnibus” Bill That Includes a $150 Million Increase for NIH

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.